Programs Opioids Clinical Primer Resources Management of opioid use disorders: a national clinical practice guideline
Management of opioid use disorders: a national clinical practice guideline

Management of opioid use disorders: a national clinical practice guideline

Evidence, Guidelines and Recommendations

This guideline was developed to provide Canadian health professionals with an educational tool and clinical practice recommendations for the treatment of opioid use disorder. These recommendations are primarily relevant for the clinical management of this disorder in adults, including young adults.

Details

Category
Evidence, Guidelines and Recommendations
Format
Web Link
Views
0
Added
Aug 25, 2025
Tags
Psychiatry
Pain
Mental Health
Substance Use Disorders
Primary Care
Internal Medicine
Emergency Medicine

Related Resources

Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline
The objective of this guideline is to provide clinical recommendations for the initiation, maintenance and discontinuation of buprenorphine/naloxone maintenance treatment in the ambulatory treatment of adults and adolescents with opioid dependence in Ontario.
Recommendations for the use of slow-release oral morphine as opioid agonist therapy
Bringing together published evidence and both clinical and experiential expertise, these recommendations are intended to guide prescribers in the use of slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT).
Slow-release oral morphine as opioid agonist therapy: Plain language summary
A summary of the recommendations, intended for patients interested in learning about SROM as OAT.

Learn more

Stay up to date

News and updates direct to your inbox.

© 2025 McMaster University & Others | 1280 Main St. W. | Hamilton, Ontario L8S 4L8 | Terms of Use